

A value-based payment model can drive collaboration between primary care physicians and oncologists to provide the best possible care for patients, said a former leader at the U.S. Centers for Medicare & Medicaid Services.
Elizabeth Fowler, JD, PhD, was a keynote speaker on May 6 at the 2025 NCCN Policy Summit: Primary Care and Oncology Collaboration for Better Patient Outcomes. The meeting was planned by the National Comprehensive Cancer Network (NCCN), a nonprofit alliance of 33 cancer centers.
Fowler, who has worked in both private and public sector settings, most recently served as CMS deputy administrator and director the Center for Medicare and Medicaid Innovation (CMMI) in the administration of President Joe Biden. There she oversaw payment and care delivery models that influenced value-based care on a national scale.
Fowler’s speech was titled “Predicting the Unpredictable: The Future of Value-Based Care and Implications for Oncology.” She explained CMS’ Oncology Care Model (OCM), which ran from July 2016 to June 2022. That model was followed by the Enhancing Oncology Model, which began in July 2023 and continues through June 2030.
OCM was an ambitious effort to test whether value-based payment could work in one of the most complex, variable and high-cost medical specialties, Fowler said.